ATE267585T1 - Micronisierte pharmazeutische zusammensetzungen - Google Patents

Micronisierte pharmazeutische zusammensetzungen

Info

Publication number
ATE267585T1
ATE267585T1 AT99949133T AT99949133T ATE267585T1 AT E267585 T1 ATE267585 T1 AT E267585T1 AT 99949133 T AT99949133 T AT 99949133T AT 99949133 T AT99949133 T AT 99949133T AT E267585 T1 ATE267585 T1 AT E267585T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
micronized pharmaceutical
micronised
micronized
pharmaceutical
Prior art date
Application number
AT99949133T
Other languages
English (en)
Inventor
Richard Anthony Flynn
Martin Harris Goldman
James Richard Lovely
Original Assignee
Pharmax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10839350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE267585(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmax Ltd filed Critical Pharmax Ltd
Application granted granted Critical
Publication of ATE267585T1 publication Critical patent/ATE267585T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99949133T 1998-09-23 1999-09-22 Micronisierte pharmazeutische zusammensetzungen ATE267585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820746.7A GB9820746D0 (en) 1998-09-23 1998-09-23 Micronised pharmaceutical compositions
PCT/GB1999/003172 WO2000016745A2 (en) 1998-09-23 1999-09-22 Micronised pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE267585T1 true ATE267585T1 (de) 2004-06-15

Family

ID=10839350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99949133T ATE267585T1 (de) 1998-09-23 1999-09-22 Micronisierte pharmazeutische zusammensetzungen

Country Status (20)

Country Link
EP (1) EP1115380B2 (de)
JP (1) JP5165168B2 (de)
CN (1) CN1148168C (de)
AT (1) ATE267585T1 (de)
AU (1) AU752266B2 (de)
BR (2) BRPI9914031B8 (de)
CA (1) CA2341366C (de)
CZ (1) CZ298603B6 (de)
DE (1) DE69917658T3 (de)
DK (1) DK1115380T4 (de)
EA (1) EA003193B1 (de)
ES (1) ES2222733T5 (de)
GB (1) GB9820746D0 (de)
HU (1) HU228888B1 (de)
IL (1) IL141913A0 (de)
MX (1) MXPA01003103A (de)
NZ (1) NZ509881A (de)
PL (1) PL197871B1 (de)
PT (1) PT1115380E (de)
WO (1) WO2000016745A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (de) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Pulverformulierung zur Inhalation
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
US10441536B2 (en) * 2013-03-13 2019-10-15 Actavis Group Ptc Ehf Micronized colistimethane sodium pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
IT1228459B (it) † 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8911259D0 (en) † 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5916596A (en) † 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5875776A (en) † 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
EP0920324B1 (de) * 1996-11-15 2001-06-27 Pathogenesis Corporation Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege

Also Published As

Publication number Publication date
WO2000016745A2 (en) 2000-03-30
NZ509881A (en) 2003-01-31
CA2341366A1 (en) 2000-03-30
WO2000016745A3 (en) 2001-05-10
PL197871B1 (pl) 2008-05-30
DK1115380T3 (da) 2004-10-04
CA2341366C (en) 2008-11-18
CZ20011050A3 (cs) 2001-09-12
ES2222733T5 (es) 2008-06-16
BRPI9914031B8 (pt) 2019-02-26
BR9914031A (pt) 2001-06-19
CZ298603B6 (cs) 2007-11-21
AU6212299A (en) 2000-04-10
PT1115380E (pt) 2004-10-29
PL346774A1 (en) 2002-02-25
EA200100253A1 (ru) 2001-08-27
DE69917658T3 (de) 2009-04-02
ES2222733T3 (es) 2005-02-01
DE69917658T2 (de) 2005-06-09
MXPA01003103A (es) 2005-02-17
HU228888B1 (en) 2013-06-28
JP2002526435A (ja) 2002-08-20
HUP0104928A2 (hu) 2002-04-29
AU752266B2 (en) 2002-09-12
IL141913A0 (en) 2002-03-10
DK1115380T4 (da) 2008-06-16
EP1115380B2 (de) 2008-03-12
CN1321082A (zh) 2001-11-07
EP1115380A2 (de) 2001-07-18
GB9820746D0 (en) 1998-11-18
DE69917658D1 (de) 2004-07-01
BR9914031B1 (pt) 2011-02-08
HUP0104928A3 (en) 2002-08-28
EA003193B1 (ru) 2003-02-27
EP1115380B1 (de) 2004-05-26
CN1148168C (zh) 2004-05-05
JP5165168B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
MY126253A (en) Capsules for inhalation
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
NL193930B (nl) Inhaleerinrichting met verpakking voor medicijn in poedervorm alsmede een dergelijke medicijnverpakking.
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
YU46095A (sh) Postupak pripreme leka za inhalacionu primenu
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO20010535L (no) Todelt kapsel for opptak av farmasøytiske preparater for pulverinhalatorer
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
YU38802A (sh) Nova kompozicija i njena upotreba
AU1811688A (en) Solid drug preparations containing micronized crystals of ebselen
NZ336592A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DE69917658D1 (de) Micronisierte pharmazeutische zusammensetzungen
GB9420748D0 (en) 1,5 benzodiazepine derivatives
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
EA200500613A1 (ru) Фармацевтические композиции с контролируемым высвобождением, содержащие альгинат натрия и альгинат натрия-кальция
ES2082524T3 (es) Medicamento de liberacion retardada que contiene un derivado de dihidropiridina en forma de nanosol y su preparacion.
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties